1. Home
  2. BDSX vs INO Comparison

BDSX vs INO Comparison

Compare BDSX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$15.28

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.48

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
INO
Founded
2005
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.5M
114.0M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
BDSX
INO
Price
$15.28
$1.48
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$32.50
$6.75
AVG Volume (30 Days)
73.6K
2.2M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
$88,499,000.00
$42,220,086.00
Revenue This Year
$25.26
$20,156.19
Revenue Next Year
$19.15
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
24.08
19.37
52 Week Low
$0.25
$1.03
52 Week High
$20.21
$2.86

Technical Indicators

Market Signals
Indicator
BDSX
INO
Relative Strength Index (RSI) 60.89 68.41
Support Level $12.77 $1.48
Resistance Level $16.26 $1.52
Average True Range (ATR) 1.22 0.09
MACD 0.61 0.05
Stochastic Oscillator 86.52 59.42

Price Performance

Historical Comparison
BDSX
INO

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Share on Social Networks: